从药物多肽到蛋白质全合成:酶促拼接的方法原理与前沿应用  

Enzymatic ligation technologies for the synthesis of pharmaceutical peptides and proteins

作　　者：杨新宇 朱彤 李瑞峰[1,2] 吴边 YANG Xinyu;ZHU Tong;LI Ruifeng;WU Bian(CAS Key Laboratory of Microbial Physiological and Metabolic Engineering,State Key Laboratory of Microbial Resources,Institute of Microbiology,Chinese Academy of Sciences,Beijing 100101,China;University of Chinese Academy of Sciences,Beijing 100049,China)

机构地区：[1]中国科学院微生物研究所,中国科学院微生物生理与代谢工程重点实验室,微生物资源前期开发国家重点实验室,北京100101 [2]中国科学院大学生命科学学院,北京100049

出　　处：《合成生物学》2021年第1期33-45,共13页Synthetic Biology Journal

基　　金：国家重点研发计划(2018YFA0901600);国家自然科学基金优秀青年科学基金(31822002);国家自然科学基金面上项目(31870055)。

摘　　要：蛋白质是生命活动的基础功能元件,其化学合成与定点修饰已成为合成生物学领域探索复杂生物大分子“结构-功能”关系的重要前沿方向。近年来,以多肽固相合成与特异性拼接为核心的蛋白质合成和修饰技术蓬勃发展,打破了生命合成系统仅能使用天然及少数非天然氨基酸的瓶颈,为制备含有数百个氨基酸残基的非天然蛋白质提供了技术平台,让原子水平的蛋白质人工设计成为现实。作为一类广受关注的多肽拼接策略,基于天然或人工改造多肽连接酶的技术方法不仅在基础研究领域拓展了人们对蛋白质这一生命核心元件的理解,还在工业领域崭露头角,被应用于多种多肽类药物的生产。针对蛋白质合成领域中酶促多肽拼接技术平台,本文介绍了Sortase A转肽酶、Butelase 1转肽酶以及Subtilisin人工连接酶的来源以及催化过程,探讨了各自的优势以及局限性,并综述了三种酶在蛋白质修饰、蛋白质合成、多肽药物环化等方面的应用。通过计算机辅助设计、定向进化等技术对转肽酶、连接酶进行改造来提升其在底物谱、催化活性等方面的特性,将化学方法与酶促方法联用来建立多样的生物大分子从头设计与合成路线是目前的主要发展趋势。As a hot-spot of synthetic biology,chemical protein synthesis and modification have been widely applied to generate and functionalize naturally inaccessible proteins to meet scientific or pharmaceutical demands.Breaking away from the restrictions on the amino acids utilized in ribosomal protein synthesis,protein synthesis,and modification through the ligation of synthetic peptides have provided a platform for preparing the unnatural proteins that contain hundreds of residues,which realizes the artificial design of protein on the atomic scale.Although several chemical ligation methods have been reported,they are confronted with the defects like limited junction choices and complicated substrate preparations,impelling the scientists to find out alternative solutions and develop enzymatic strategies fit for different applications.As a group of popular peptide ligation methods,enzymatic ligation strategies not only expand our understanding of protein,but also exhibit great advantages in the industrial production of pharmaceutical peptides.Sortase A(SrtA)has been extensively utilized for protein terminal modification.The researchers from various fields have attempted to develop novel applications based on SrtA,for instance,characterizing the surface proteins of eukaryotic cells and expanding the choices of phage capsid proteins.Butelase 1 from a cyclopeptide-producing plant(Clitoria ternatea)is a highly efficient peptide ligase for peptide cyclization.Large proteins like GFP could be cyclized with excellent yield(>95%)as well,and Butelase 1 can be used for synthesizing peptide dendrimers,preparing protein thioesters,and modifying bacterial surfaces as well.Subtilisin-derived ligase is engineered from subtilisin and thought as a powerful tool for peptide cyclization,protein synthesis and terminal modification.In recent years,based on a calcium-independent subtilisin variant,a thermostable and organic solvent-tolerant peptide ligase was constructed and termed Peptiligase,which was further engineered afterward.Omniligase

关 键 词：蛋白质合成 蛋白质定点修饰 Sortase A转肽酶 Butelase 1转肽酶 Subtilisin人工连接酶 

分 类 号：Q51[生物学—生物化学]